Repare Therapeutics Inc. Files 8-K: Material Agreement
| Field | Detail |
|---|---|
| Company | Repare Therapeutics Inc. |
| Form Type | 8-K |
| Filed Date | Jul 16, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, regulation-fd
TL;DR
Repare Therapeutics signed a big deal, filing an 8-K on July 15, 2025.
AI Summary
On July 15, 2025, Repare Therapeutics Inc. entered into a material definitive agreement. The company also made a Regulation FD disclosure and filed financial statements and exhibits. Specific details of the agreement and financial information were not provided in this excerpt.
Why It Matters
This filing indicates a significant new agreement for Repare Therapeutics, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which often carries significant implications and potential risks for a company.
Key Players & Entities
- Repare Therapeutics Inc. (company) — Registrant
- July 15, 2025 (date) — Date of earliest event reported
- 001-39335 (other) — Commission File Number
- 7171 Frederick-Banting, Building 2, Suite 270 (address) — Principal Executive Offices
- St-Laurent, Québec, Canada (location) — Principal Executive Offices Location
- H4S 1Z9 (zip_code) — Principal Executive Offices Zip Code
- ( 857 ) 412-7018 (phone_number) — Registrant's Telephone Number
FAQ
What is the nature of the material definitive agreement entered into by Repare Therapeutics Inc. on July 15, 2025?
The provided excerpt does not specify the details of the material definitive agreement.
What is the Commission File Number for Repare Therapeutics Inc.?
The Commission File Number for Repare Therapeutics Inc. is 001-39335.
Where are Repare Therapeutics Inc.'s principal executive offices located?
Repare Therapeutics Inc.'s principal executive offices are located at 7171 Frederick-Banting, Building 2, Suite 270, St-Laurent, Québec, Canada, H4S 1Z9.
What is the telephone number for Repare Therapeutics Inc.?
The telephone number for Repare Therapeutics Inc. is (857) 412-7018.
What items are being reported in this 8-K filing?
This 8-K filing reports on the Entry into a Material Definitive Agreement, Regulation FD Disclosure, and Financial Statements and Exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding Repare Therapeutics Inc..